Day7 and low-quality blastocysts: opt in or opt out? A dilemma with important clinical implications

Affiliations

• ¹ IVIRMA Global Research Alliance, GENERA, Rome, Italy.
• ² Columbia University Fertility Center, New York, New York.
• ³ Morbeck Consulting Ltd., Auckland, New Zealand; Department of Obstetrics and Gynecology, Monash University, Melbourne, Australia.
• ⁴ Westmead Fertility Centre, Institute of Reproductive Medicine, University of Sydney, Westmead, New South Wales, Australia.
• ⁵ Innovation Fertility, New York, New York.
• ⁶ The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, New York.
• ⁷ Biomedical Institute for Multimorbidity, Hull York Medical School, University of Hull, Hull, United Kingdom.
• ⁸ IVIRMA Global Research Alliance, GENERA, Rome, Italy; Department of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy. Electronic address: laura.rienzi@ivirma.com.